Blog

//Blog

Israeli researchers say new treatment could boost fertility in women and men

#MedicalScientists say single dose of compound developed at #Ben-GurionUniversity could speed up #eggmaturation and #ovulation By SHOSHANNA SOLOMON A lab at Ben-Gurion University (Courtesy) #Israeliresearchers say they may have found a new compound that can help #boostfertility in both men and women. #BGNTechnologies, the technology transfer company of Ben-Gurion University (BGU), said this week that [...]

By | 2018-05-03T15:54:16+00:00 May 3rd, 2018|Blog|Comments Off on Israeli researchers say new treatment could boost fertility in women and men

Eye implants for glaucoma patients inspired by Butterfly wings

May 01, 2018  - RESEARCH Inspired by tiny structures on transparent #butterflywings, scientists have developed a light-#manipulatingsurface for more effective and longer-lasting #eyeimplants for #glaucoma patients. Sections of the wings of a #longtailglasswing #butterfly are almost perfectly transparent, according to the research published in the journal Nature #Nanotechnology. Researchers at California Institute of Technology [...]

By | 2018-05-03T12:22:59+00:00 May 3rd, 2018|Blog|Comments Off on Eye implants for glaucoma patients inspired by Butterfly wings

Israeli cancer profiling co NovellusDx raises $6m

NovellusDx CEO: The funds will let us move into commercialization and enable us to meet the need for functional oncology worldwide. #Israeli #functionalgenomics and #cancer profiling company #NovellusDx today announced it has completed a $6 million #financing round with the participation of Helsinn #InvestmentFund S.A. SICAR, part of Helsinn Group, a leading cancer care [...]

By | 2018-05-02T16:53:42+00:00 May 2nd, 2018|Blog|Comments Off on Israeli cancer profiling co NovellusDx raises $6m

FDA clears Pluristem radiation treatment for emergency use

Tova Cohen | Reuters Biologists work in a laboratory at Pluristem Therapeutics in Haifa. A laboratory worker removes cells from a storage unit at Pluristem Therapeutics in Haifa, Israel March 6, 2016. REUTERS/BAZ RATNER (Reuters) - Pluristem Therapeutics Inc, a developer of #placenta-based #stemcell products, said the U.S. Food and Drug Administration has cleared the [...]

By | 2018-05-02T15:14:07+00:00 May 2nd, 2018|Blog|Comments Off on FDA clears Pluristem radiation treatment for emergency use

United Therapeutics pens $216M deal to buy SteadyMed, neutralizing pump-based threat to PAH franchise

by Nick Paul Taylor | FierceBiotech | Apr 30, 2018 SteadyMed's pump technology. (SteadyMed) United #Therapeutics has struck a $216 million deal to buy #SteadyMed. The acquisition enables United to eliminate a potential threat by taking control of a #startup that has been fighting to invalidate its patents and mount a #pump-based attack on its #pulmonaryarterialhypertension (PAH) #franchise. [...]

By | 2018-05-02T09:26:54+00:00 May 2nd, 2018|Blog|Comments Off on United Therapeutics pens $216M deal to buy SteadyMed, neutralizing pump-based threat to PAH franchise

Measuring glucose without need for finger-prick blood test

APRIL 11, 2018 | NanoMagazine Scientists at Bath University have developed a wearable sensor that measures glucose levels through the skin, an advance that could mark the end of finger-prick blood tests for diabetics. The non-invasive patch is said to draw glucose from fluid between cells across hair follicles, which are accessed via an array of [...]

By | 2018-05-01T11:24:09+00:00 May 1st, 2018|Blog|Comments Off on Measuring glucose without need for finger-prick blood test

Israeli Medical Device Developer V-Wave Raises $70 Million

V-Wave develops a minimally #invasive #implanted #shuntdevice for treating patients with severe #heartfailure Meir Orbach | 26.04.18 | CTech  Israeli #medical shunt #developer V-Wave Ltd. announced on Thursday it completed a $70 million series C financing round led by U.S. #investment firm Deerfield Management Company, L.P. with participation from medtech funds Endeavour Vision SA, Quark Venture [...]

By | 2018-04-29T09:00:24+00:00 April 29th, 2018|Blog|Comments Off on Israeli Medical Device Developer V-Wave Raises $70 Million

Eloxx Pharmaceuticals raises $50m on Nasdaq

News| Globes The company is developing a drug for treatment of cystic fibrosis. Eloxx Pharmaceuticals, which develops drugs for rare genetic diseases, announced that it has raised $50 million at $9.75 per share, 8% lower than yesterday's market price. The company will be listed on Nasdaq following its financing round. Eloxx, which merged a [...]

By | 2018-04-29T08:34:51+00:00 April 29th, 2018|Blog|Comments Off on Eloxx Pharmaceuticals raises $50m on Nasdaq

U.S. FDA Clears Pluristem’s Phase III Study in Treatment of Muscle Injury Following Hip Fracture Surgery

Multinational study expected to include clinical sites in U.S. Israel and Europe, where study has been awarded an $8.7 million grant from European Horizon 2020 Program April 25, 2018 07:00 ET | Source: Pluristem Therapeutics, Inc. HAIFA, Israel, April 25, 2018 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, announced today that [...]

By | 2018-04-26T12:44:13+00:00 April 26th, 2018|Blog|Comments Off on U.S. FDA Clears Pluristem’s Phase III Study in Treatment of Muscle Injury Following Hip Fracture Surgery

The Rise of #Nanomedicine

APRIL 18, 2018 | Research | NanoMagazine Medicine has been around for thousands of years, but as always, medicine is changing. Throughout the years, humans have switched from apothecary to packing active pharmaceutical ingredients (APIs) into #ingestibleDrugs, and now, #nanomedicine is developing into the medicine of the future. Here, we look at how nanomedicine is being [...]

By | 2018-04-25T14:35:17+00:00 April 25th, 2018|Blog|Comments Off on The Rise of #Nanomedicine